Latest Derivatives News

5E Advanced Materials has successfully closed an oversubscribed US$36 million public offering, positioning itself to advance its boron operations and finalise key commercial contracts.

Peak Processing Limited has completed a strategic rebrand and organisational restructure, securing new long-term manufacturing agreements and expanding product listings to strengthen its foothold in North America's regulated cannabis beverage markets.

RareX Limited has secured a pivotal mining lease for its Cummins Range Rare Earths Project in Western Australia, confirming some of the highest-grade gallium mineralisation in the country. The company also advances metallurgical testing and forges strategic US partnerships, positioning itself at the forefront of critical minerals development.

Redstone Resources has reported significant new high-grade copper intersections at unprecedented depths beneath its Tollu Copper deposit in Western Australia, hinting at a larger magmatic sulphide system. The company also secured government grants and raised capital to advance exploration.

Critica Limited has confirmed repeatable high-grade rare earth product quality at its Jupiter Project, delivering an 86% TREO concentrate and demonstrating gallium by-product potential. The company also secured an oversubscribed $8 million placement to fund pilot operations and a scoping study.

Nine Entertainment Co. is reshaping its media portfolio with the acquisition of QMS Media, the sale of its radio assets, and a regional TV affiliate deal, aiming to boost digital revenue to over 60% by FY27.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

Sovereign Metals has successfully recovered a high-value heavy rare earth concentrate from its Kasiya project in Malawi, while securing a strategic collaboration with the World Bank’s IFC to underpin sustainable development and financing.

Brightstar Resources has released an updated Definitive Feasibility Study for its Goldfields Project, outlining a robust six-year production plan averaging 75,000 ounces of gold annually and a pre-tax NPV of A$606 million. The study highlights a new 1.5Mtpa processing plant with expansion potential and a clear pathway to first gold by mid-2027.

Arovella Therapeutics has secured a crucial regulatory nod from the U.S. FDA, allowing its lead CAR-iNKT cell therapy, ALA-101, to enter first-in-human clinical trials targeting blood cancers.

De.mem Limited has reported its strongest December quarter yet, with record cash receipts and a positive operating cash flow for the full year, underpinned by recurring revenues and strategic expansion into the gold mining sector.

Aurum Resources has reported further high-grade gold intercepts at its BMT3 deposit within the Boundiali Gold Project, reinforcing resource confidence ahead of key 2026 milestones. The company is advancing aggressive drilling and development plans backed by a strong cash position.